Fusobacterium nucleatum: A commensal-turned pathogen

Current Opinion in Microbiology

Volumn 23, Issue , 2015, Pages 141-147

  Han, Yiping W ^a,b  

^a New York Presbyterian Morgan Stanley Children's Hospital   (United States)

^b Department of Neurology and the Taub Institute for Research on Alzheimer's Disease and the Aging Brain   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADHESIN; INVASIN; VIRULENCE FACTOR;

ALZHEIMER DISEASE; APPENDICITIS; BACTERIAL COLONIZATION; BACTERIAL VIRULENCE; CARDIOVASCULAR DISEASE; CHORIOAMNIONITIS; COLORECTAL CANCER; COMMENSAL; FUSOBACTERIUM INFECTION; FUSOBACTERIUM NUCLEATUM; HUMAN; IMMUNE RESPONSE; INFLAMMATORY BOWEL DISEASE; LEMIERRE SYNDROME; MOUTH INFECTION; NEWBORN SEPSIS; NONHUMAN; PREECLAMPSIA; PREGNANCY OUTCOME; PREMATURE LABOR; RESPIRATORY TRACT INFECTION; REVIEW; RHEUMATOID ARTHRITIS; STILLBIRTH; ANAEROBIC BACTERIUM; CELL TRANSFORMATION; COMPLICATION; FEMALE; GROWTH, DEVELOPMENT AND AGING; INFLAMMATION; MALE; METABOLISM; MICROBIOLOGY; PATHOGENICITY; PATHOLOGY; PREGNANCY; PREGNANCY COMPLICATION; VIRULENCE;

FUSOBACTERIUM NUCLEATUM;

BACTERIA, ANAEROBIC; CELL TRANSFORMATION, NEOPLASTIC; FEMALE; FUSOBACTERIUM INFECTIONS; FUSOBACTERIUM NUCLEATUM; HUMANS; INFLAMMATION; MALE; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; VIRULENCE; VIRULENCE FACTORS;

EID: 84920918375     PISSN: 13695274     EISSN: 18790364     Source Type: Journal    
DOI: 10.1016/j.mib.2014.11.013     Document Type: Review

References (105)

1. Aagaard K., Riehle K., Ma J., Segata N., Mistretta T.A., Coarfa C., Raza S., Rosenbaum S., Van den Veyver I., Milosavljevic A., et al. A metagenomic approach to characterization of the vaginal microbiome signature in pregnancy. PLoS ONE 2012, 7:e36466.
2. Segata N., Haake S.K., Mannon P., Lemon K.P., Waldron L., Gevers D., Huttenhower C., Izard J. Composition of the adult digestive tract bacterial microbiome based on seven mouth surfaces, tonsils, throat and stool samples. Genome Biol 2012, 13:R42.
3. Han Y.W., Wang X. Mobile microbiome oral bacteria in extra-oral infections and inflammation. J Dent Res 2013.
4. Gharbia S.E., Shah H.N. Fusobacterium nucleatum subsp. fusiforme subsp. nov. and Fusobacterium nucleatum subsp. animalis subsp. nov. as additional subspecies within Fusobacterium nucleatum. Int J Syst Bacteriol 1992, 42:296-298.
5. Gharbia S.E., Shah H.N. Heterogeneity within Fusobacterium nucleatum, proposal of four subspecies. Lett Appl Microbiol 1990, 10:105-108.
6. Allen-Vercoe E., Strauss J., Chadee K. Fusobacterium nucleatum: an emerging gut pathogen?. Gut Microbes 2011, 2:294-298.
7. Field C.A., Gidley M.D., Preshaw P.M., Jakubovics N. Investigation and quantification of key periodontal pathogens in patients with type 2 diabetes. J Periodontal Res 2012, 47:470-478.
8. Moore W.E., Moore L.V. The bacteria of periodontal diseases. Periodontology 2000 1994, 5:66-77.
9. Griffen A.L., Beall C.J., Campbell J.H., Firestone N.D., Kumar P.S., Yang Z.K., Podar M., Leys E.J. Distinct and complex bacterial profiles in human periodontitis and health revealed by 16S pyrosequencing. ISME J 2012, 6:1176-1185.
10. Loozen G., Ozcelik O., Boon N., De Mol A., Schoen C., Quirynen M., Teughels W. Inter-bacterial correlations in subgingival biofilms: a large-scale survey. J Clin Periodontol 2014, 41:1-10.
11. Saygun I., Nizam N., Keskiner I., Bal V., Kubar A., Acikel C., Serdar M., Slots J. Salivary infectious agents and periodontal disease status. J Periodontal Res 2011, 46:235-239.
12. Feng X., Zhang L., Xu L., Meng H., Lu R., Chen Z., Shi D., Wang X. Detection of eight periodontal microorganisms and distribution of Porphyromonas gingivalis fimA genotypes in chinese patients with aggressive periodontitis. J Periodontol 2014, 85:150-159.
13. Liu P., Liu Y., Wang J., Guo Y., Zhang Y., Xiao S. Detection of Fusobacterium nucleatum and fadA adhesin gene in patients with orthodontic gingivitis and non-orthodontic periodontal inflammation. PLOS ONE 2014, 9:e85280.
14. Yang N.Y., Zhang Q., Li J.L., Yang S.H., Shi Q. Progression of periodontal inflammation in adolescents is associated with increased number of Porphyromonas gingivalis, Prevotella intermedia, Tannerella forsythensis, and Fusobacterium nucleatum. Int J Paediatr Dent 2014, 24:226-233.
15. Kistler J.O., Booth V., Bradshaw D.J., Wade W.G. Bacterial community development in experimental gingivitis. PLOS ONE 2013, 8:e71227.
16. Didilescu A.C., Rusu D., Anghel A., Nica L., Iliescu A., Greabu M., Bancescu G., Stratul S.I. Investigation of six selected bacterial species in endo-periodontal lesions. Int Endod J 2012, 45:282-293.
17. Fujii R., Saito Y., Tokura Y., Nakagawa K.I., Okuda K., Ishihara K. Characterization of bacterial flora in persistent apical periodontitis lesions. Oral Microbiol Immunol 2009, 24:502-505.
18. Siqueira J.F., Rocas I.N., Paiva S.S., Magalhaes K.M., Guimaraes-Pinto T. Cultivable bacteria in infected root canals as identified by 16S rRNA gene sequencing. Oral Microbiol Immunol 2007, 22:266-271.
19. Triches T.C., de Figueiredo L.C., Feres M., de Freitas S.F., Zimmermann G.S., Cordeiro M.M. Microbial profile of root canals of primary teeth with pulp necrosis and periradicular lesion. J Dent Child (Chic) 2014, 81:14-19.
20. Topcuoglu N., Bozdogan E., Kulekci G. Presence of oral bacterial species in primary endodontic infections of primary teeth. J Clin Pediatr Dent 2013, 38:155-160.
21. Rocas I.N., Siqueira J.F., Debelian G.J. Analysis of symptomatic and asymptomatic primary root canal infections in adult Norwegian patients. J Endod 2011, 37:1206-1212.
22. Siqueira J.F., Rocas I.N. The microbiota of acute apical abscesses. J Dent Res 2009, 88:61-65.
23. Riep B., Edesi-Neuss L., Claessen F., Skarabis H., Ehmke B., Flemmig T.F., Bernimoulin J.P., Gobel U.B., Moter A. Are putative periodontal pathogens reliable diagnostic markers?. J Clin Microbiol 2009, 47:1705-1711.
24. Lourenco T.G., Heller D., Silva-Boghossian C.M., Cotton S.L., Paster B.J., Colombo A.P. Microbial signature profiles of periodontally healthy and diseased patients. J Clin Periodontol 2014, 41:1027-1036.
25. Gharbia S.E., Shah H.N., Lawson P.A., Haapasalo M. Distribution and frequency of Fusobacterium nucleatum subspecies in the human oral cavity. Oral Microbiol Immunol 1990, 5:324-327.
26. Zhou X., Liu X., Li J., Aprecio R.M., Zhang W., Li Y. Real-time PCR quantification of six periodontal pathogens in saliva samples from healthy young adults. Clin Oral Investig 2014, [Epub ahead of print].
27. Vincent J.W., Suzuki J.B., Falkler W.A., Cornett W.C. Reaction of human sera from juvenile periodontitis, rapidly progressive periodontitis, and adult periodontitis patients with selected periodontopathogens. J Periodontol 1985, 56:464-469.
28. Moon J.H., Lee J.H., Lee J.Y. Subgingival microbiome in smokers and non-smokers in Korean chronic periodontitis patients. Mol Oral Microbiol 2014, [Epub ahead of print].
29. Mason M.R., Preshaw P.M., Nagaraja H.N., Dabdoub S.M., Rahman A., Kumar P.S. The subgingival microbiome of clinically healthy current and never smokers. ISME J 2014, [Epub ahead of print].
30. Casarin R.C., Barbagallo A., Meulman T., Santos V.R., Sallum E.A., Nociti F.H., Duarte P.M., Casati M.Z., Goncalves R.B. Subgingival biodiversity in subjects with uncontrolled type-2 diabetes and chronic periodontitis. J Periodontal Res 2013, 48:30-36.
31. Chaushu S., Wilensky A., Gur C., Shapira L., Elboim M., Halftek G., Polak D., Achdout H., Bachrach G., Mandelboim O. Direct recognition of Fusobacterium nucleatum by the NK cell natural cytotoxicity receptor NKp46 aggravates periodontal disease. PLoS Pathog 2012, 8:e1002601.
32. Kuriyama T., Nakagawa K., Kawashiri S., Yamamoto E., Nakamura S., Karasawa T. The virulence of mixed infection with Streptococcus constellatus and Fusobacterium nucleatum in a murine orofacial infection model. Microbes Infect 2000, 2:1425-1430.
33. Nagashima H., Takao A., Maeda N. Abscess forming ability of streptococcus milleri group: synergistic effect with Fusobacterium nucleatum. Microbiol Immunol 1999, 43:207-216.
34. Settem R.P., El-Hassan A.T., Honma K., Stafford G.P., Sharma A. Fusobacterium nucleatum and Tannerella forsythia induce synergistic alveolar bone loss in a mouse periodontitis model. Infect Immun 2012, 80:2436-2443.
35. Polak D., Wilensky A., Shapira L., Halabi A., Goldstein D., Weiss E.I., Houri-Haddad Y. Mouse model of experimental periodontitis induced by Porphyromonas gingivalis/Fusobacterium nucleatum infection: bone loss and host response. J Clin Periodontol 2009, 36:406-410.
36. Kesavalu L., Sathishkumar S., Bakthavatchalu V., Matthews C., Dawson D., Steffen M., Ebersole J.L. Rat model of polymicrobial infection, immunity, and alveolar bone resorption in periodontal disease. Infect Immun 2007, 75:1704-1712.
37. Wang X., Buhimschi C.S., Temoin S., Bhandari V., Han Y.W., Buhimschi I.A. Comparative microbial analysis of paired amniotic fluid and cord blood from pregnancies complicated by preterm birth and early-onset neonatal sepsis. PLOS ONE 2013, 8:e56131.
38. Han Y.W., Fardini Y., Chen C., Iacampo K.G., Peraino V.A., Shamonki J.M., Redline R.W. Term stillbirth caused by oral Fusobacterium nucleatum. Obstet Gynecol 2010, 115:442-445.
39. Han Y.W., Shen T., Chung P., Buhimschi I.A., Buhimschi C.S. Uncultivated bacteria as etiologic agents of intra-amniotic inflammation leading to preterm birth. J Clin Microbiol 2009, 47:38-47.
40. Bohrer J.C., Kamemoto L.E., Almeida P.G., Ogasawara K.K. Acute chorioamnionitis at term caused by the oral pathogen Fusobacterium nucleatum. Hawaii J Med Public Health 2012, 71:280-281.
41. Gauthier S., Tetu A., Himaya E., Morand M., Chandad F., Rallu F., Bujold E. The origin of Fusobacterium nucleatum involved in intra-amniotic infection and preterm birth. J Matern Fetal Neonatal Med 2011, 24:1329-1332.
42. Dixon N.G., Ebright D., Defrancesco M.A., Hawkins R.E. Orogenital contact: a cause of chorioamnionitis?. Obstet Gynecol 1994, 84:654-655.
43. Cahill R.J., Tan S., Dougan G., O'Gaora P., Pickard D., Kennea N., Sullivan M.H., Feldman R.G., Edwards A.D. Universal DNA primers amplify bacterial DNA from human fetal membranes and link Fusobacterium nucleatum with prolonged preterm membrane rupture. Mol Hum Reprod 2005, 11:761-766.
44. Weible D.R., Randall H.W. Evaluation of amniotic fluid in preterm labor with intact membranes. J Reprod Med 1985, 30:777-780.
45. Barak S., Oettinger-Barak O., Machtei E.E., Sprecher H., Ohel G. Evidence of periopathogenic microorganisms in placentas of women with preeclampsia. J Periodontol 2007, 78:670-676.
46. Chaim W., Mazor M. Intraamniotic infection with fusobacteria. Arch Gynecol Obstet 1992, 251:1-7.
47. Hill G.B. Preterm birth: associations with genital and possibly oral microflora. Ann Periodontol 1998, 3:222-232.
48. Han Y.W. Oral health and adverse pregnancy outcomes-what's next?. J Dent Res 2011, 90:289-293.
49. Han Y.W. Can oral bacteria cause pregnancy complications?. Womens Health (Lond Engl) 2011, 7:401-404.
50. Hill G.B. Investigating the source of amniotic fluid isolates of fusobacteria. Clin Infect Dis 1993, 16(Suppl. 4):S423-S424.
51. Han Y.W., Redline R.W., Li M., Yin L., Hill G.B., McCormick T.S. Fusobacterium nucleatum induces premature and term stillbirths in pregnant mice: implication of oral bacteria in preterm birth. Infect Immun 2004, 72:2272-2279.
52. Liu H., Redline R.W., Han Y.W. Fusobacterium nucleatum induces fetal death in mice via stimulation of TLR4-mediated placental inflammatory response. J Immunol 2007, 179:2501-2508.
53. Aagaard K., Ma J., Antony K.M., Ganu R., Petrosino J., Versalovic J. The placenta harbors a unique microbiome. Sci Transl Med 2014, 6:237ra265.
54. Fardini Y., Chung P., Dumm R., Joshi N., Han Y.W. Transmission of diverse oral bacteria to murine placenta: evidence for the oral microbiome as a potential source of intrauterine infection. Infect Immun 2010, 78:1789-1796.
55. Abad C., Antczak D.F., Carvalho J., Chamley L.W., Chen Q., Daher S., Damiano A.E., Dantzer V., Diaz P., Dunk C.E., et al. IFPA meeting workshop report I: immunology; ion transport; epigenetics; vascular reactivity; epitheliochorial placentation; proteomics. Placenta 2010, 32(Suppl. 2):S81-S89.
56. Jeffcoat M., Parry S., Gerlach R.W., Doyle M.J. Use of alcohol-free antimicrobial mouth rinse is associated with decreased incidence of preterm birth in a high-risk population. Am J Obstet Gynecol 2011, 205:382. e381-386.
57. Lopez N.J., Da Silva I., Ipinza J., Gutierrez J. Periodontal therapy reduces the rate of preterm low birth weight in women with pregnancy-associated gingivitis. J Periodontol 2005, 76:2144-2153.
58. Radnai M., Pal A., Novak T., Urban E., Eller J., Gorzo I. Benefits of periodontal therapy when preterm birth threatens. J Dent Res 2009, 88:280-284.
59. Macones G.A., Parry S., Nelson D.B., Strauss J.F., Ludmir J., Cohen A.W., Stamilio D.M., Appleby D., Clothier B., Sammel M.D., et al. Treatment of localized periodontal disease in pregnancy does not reduce the occurrence of preterm birth: results from the Periodontal Infections and Prematurity Study (PIPS). Am J Obstet Gynecol 2010, 202:147. e141-148.
60. Michalowicz B.S., Hodges J.S., DiAngelis A.J., Lupo V.R., Novak M.J., Ferguson J.E., Buchanan W., Bofill J., Papapanou P.N., Mitchell D.A., et al. Treatment of periodontal disease and the risk of preterm birth. N Engl J Med 2006, 355:1885-1894.
61. Offenbacher S., Beck J.D., Jared H.L., Mauriello S.M., Mendoza L.C., Couper D.J., Stewart D.D., Murtha A.P., Cochran D.L., Dudley D.J., et al. Effects of periodontal therapy on rate of preterm delivery: a randomized controlled trial. Obstet Gynecol 2009, 114:551-559.
62. Marchesi J.R., Dutilh B.E., Hall N., Peters W.H., Roelofs R., Boleij A., Tjalsma H. Towards the human colorectal cancer microbiome. PLoS ONE 2011, 6:e20447.
63. Chen W., Liu F., Ling Z., Tong X., Xiang C. Human intestinal lumen and mucosa-associated microbiota in patients with colorectal cancer. PLoS ONE 2012, 7:e39743.
64. Castellarin M., Warren R.L., Freeman J.D., Dreolini L., Krzywinski M., Strauss J., Barnes R., Watson P., Allen-Vercoe E., Moore R.A., et al. Fusobacterium nucleatum infection is prevalent in human colorectal carcinoma. Genome Res 2012, 22:299-306.
65. Kostic A.D., Gevers D., Pedamallu C.S., Michaud M., Duke F., Earl A.M., Ojesina A.I., Jung J., Bass A.J., Tabernero J., et al. Genomic analysis identifies association of Fusobacterium with colorectal carcinoma. Genome Res 2012, 22:292-298.
66. Kostic A.D., Chun E., Robertson L., Glickman J.N., Gallini C.A., Michaud M., Clancy T.E., Chung D.C., Lochhead P., Hold G.L., et al. Fusobacterium nucleatum potentiates intestinal tumorigenesis and modulates the tumor-Immune microenvironment. Cell Host Microbe 2013, 14:207-215.
67. McCoy A.N., Araujo-Perez F., Azcarate-Peril A., Yeh J.J., Sandler R.S., Keku T.O. Fusobacterium is associated with colorectal adenomas. PLOS ONE 2013, 8:e53653.
68. Rubinstein M.R., Wang X., Liu W., Hao Y., Cai G., Han Y.W. Fusobacterium nucleatum promotes colorectal carcinogenesis by modulating E-cadherin/β-catenin signaling via its FadA adhesin. Cell Host Microbe 2013, 14:195-206.
69. Flanagan L., Schmid J., Ebert M., Soucek P., Kunicka T., Liska V., Bruha J., Neary P., Dezeeuw N., Tommasino M., et al. Fusobacterium nucleatum associates with stages of colorectal neoplasia development, colorectal cancer and disease outcome. Eur J Clin Microbiol Infect Dis 2014, 33:1381-1390.
70. Mira-Pascual L., Cabrera-Rubio R., Ocon S., Costales P., Parra A., Suarez A., Moris F., Rodrigo L., Mira A., Collado M.C. Microbial mucosal colonic shifts associated with the development of colorectal cancer reveal the presence of different bacterial and archaeal biomarkers. J Gastroenterol 2014, [Epub ahead of print].
71. Warren R.L., Freeman D.J., Pleasance S., Watson P., Moore R.A., Cochrane K., Allen-Vercoe E., Holt R.A. Co-occurrence of anaerobic bacteria in colorectal carcinomas. Microbiome 2013, 1:16.
72. Tjalsma H., Boleij A., Marchesi J.R., Dutilh B.E. A bacterial driver-passenger model for colorectal cancer: beyond the usual suspects. Nat Rev Microbiol 2012, 10:575-582.
73. Keku T.O., McCoy A.N., Azcarate-Peril A.M. Fusobacterium spp. and colorectal cancer: cause or consequence?. Trends Microbiol 2013, 21:506-508.
74. Zhu Q., Jin Z., Wu W., Gao R., Guo B., Gao Z., Yang Y., Qin H. Analysis of the intestinal lumen microbiota in an animal model of colorectal cancer. PLOS ONE 2014, 9:e90849.
75. Allen-Vercoe E., Jobin C. Fusobacterium and Enterobacteriaceae. Important players for CRC?. Immunol Lett 2014, 5(6). e01864-14. 10.1128/mBio.01864-14.
76. Tahara T., Shibata T., Kawamura T., Okubo M., Ichikawa Y., Sumi K., Miyata M., Ishizuka T., Nakamura M., Nagasaka M., et al. Fusobacterium detected in colonic biopsy and clinicopathological features of ulcerative colitis in Japan. Dig Dis Sci 2014, [Epub ahead of print].
77. Strauss J., Kaplan G.G., Beck P.L., Rioux K., Panaccione R., Devinney R., Lynch T., Allen-Vercoe E. Invasive potential of gut mucosa-derived fusobacterium nucleatum positively correlates with IBD status of the host. Inflamm Bowel Dis 2011, 17:1971-1978.
78. Swidsinski A., Dorffel Y., Loening-Baucke V., Theissig F., Ruckert J.C., Ismail M., Rau W.A., Gaschler D., Weizenegger M., Kuhn S., et al. Acute appendicitis is characterised by local invasion with Fusobacterium nucleatum/necrophorum. Gut 2011, 60:34-40.
79. Swidsinski A., Dorffel Y., Loening-Baucke V., Tertychnyy A., Biche-Ool S., Stonogin S., Guo Y., Sun N.D. Mucosal invasion by fusobacteria is a common feature of acute appendicitis in Germany, Russia, and China. Saudi J Gastroenterol 2012, 18:55-58.
80. Zhong D., Brower-Sinning R., Firek B., Morowitz M.J. Acute appendicitis in children is associated with an abundance of bacteria from the phylum Fusobacteria. J Pediatr Surg 2014, 49:441-446.
81. Brook I. Fusobacterial infections in children. Curr Infect Dis Rep 2013, 15:288-294.
82. Han Y.W. Fusobacterium nucleatum interaction with host cells. Oral Microbial Communities: Genomic Inquiry and Interspecies Communication 2011, ASM Press. P. Kolenbrander (Ed.).
83. Williams M.D., Kerber C.A., Tergin H.F. Unusual presentation of Lemierre's syndrome due to Fusobacterium nucleatum. J Clin Microbiol 2003, 41:3445-3448.
84. Ford P.J., Gemmell E., Chan A., Carter C.L., Walker P.J., Bird P.S., West M.J., Cullinan M.P., Seymour G.J. Inflammation, heat shock proteins and periodontal pathogens in atherosclerosis: an immunohistologic study. Oral Microbiol Immunol 2006, 21:206-211.
85. Figuero E., Sanchez-Beltran M., Cuesta-Frechoso S., Tejerina J.M., del Castro J.A., Gutierrez J.M., Herrera D., Sanz M. Detection of periodontal bacteria in atheromatous plaque by nested polymerase chain reaction. J Periodontol 2011, 82:1469-1477.
86. Pyysalo M.J., Pyysalo L.M., Pessi T., Karhunen P.J., Ohman J.E. The connection between ruptured cerebral aneurysms and odontogenic bacteria. J Neurol Neurosurg Psychiatry 2013, 84:1214-1218.
87. Elkaim R., Dahan M., Kocgozlu L., Werner S., Kanter D., Kretz J.G., Tenenbaum H. Prevalence of periodontal pathogens in subgingival lesions, atherosclerotic plaques and healthy blood vessels: a preliminary study. J Periodontal Res 2008, 43:224-231.
88. Sparks Stein P., Steffen M.J., Smith C., Jicha G., Ebersole J.L., Abner E., Dawson D. Serum antibodies to periodontal pathogens are a risk factor for Alzheimer's disease. Alzheimers Dement 2012, 8:196-203.
89. Temoin S., Chakaki A., Askari A., El-Halaby A., Fitzgerald S., Marcus R.E., Han Y.W., Bissada N.F. Identification of oral bacterial DNA in synovial fluid of patients with arthritis with native and failed prosthetic joints. J Clin Rheumatol 2012, 18:117-121.
90. Ortiz P., Bissada N.F., Palomo L., Han Y.W., Al-Zahrani M.S., Panneerselvam A., Askari A. Periodontal therapy reduces the severity of active rheumatoid arthritis in patients treated with or without tumor necrosis factor inhibitors. J Periodontol 2009, 80:535-540.
91. Rickard A.H., Gilbert P., High N.J., Kolenbrander P.E., Handley P.S. Bacterial coaggregation: an integral process in the development of multi-species biofilms. Trends Microbiol 2003, 11:94-100.
92. Kaplan A., Kaplan C.W., He X., McHardy I., Shi W., Lux R. Characterization of aid1, a novel gene involved in Fusobacterium nucleatum interspecies interactions. Microb Ecol 2014, 68:379-387.
93. Kaplan C.W., Lux R., Haake S.K., Shi W. The Fusobacterium nucleatum outer membrane protein RadD is an arginine-inhibitable adhesin required for inter-species adherence and the structured architecture of multispecies biofilm. Mol Microbiol 2009, 71:35-47.
94. Kaplan C.W., Ma X., Paranjpe A., Jewett A., Lux R., Kinder-Haake S., Shi W. Fusobacterium nucleatum outer membrane proteins Fap2 and RadD induce cell death in human lymphocytes. Infect Immun 2010, 78:4773-4778.
95. Bachrach G., Ianculovici C., Naor R., Weiss E.I. Fluorescence based measurements of Fusobacterium nucleatum coaggregation and of fusobacterial attachment to mammalian cells. FEMS Microbiol Lett 2005, 248:235-240.
96. Han Y.W., Shi W., Huang G.T., Kinder Haake S., Park N.H., Kuramitsu H., Genco R.J. Interactions between periodontal bacteria and human oral epithelial cells: Fusobacterium nucleatum adheres to and invades epithelial cells. Infect Immun 2000, 68:3140-3146.
97. Manson McGuire A., Cochrane K., Griggs A.D., Haas B.J., Abeel T., Zeng Q., Nice J.B., MacDonald H., Birren B.W., Berger B.W., et al. Evolution of invasion in a diverse set of fusobacterium species. MBio 2014, 5.
98. Xu M., Yamada M., Li M., Liu H., Chen S.G., Han Y.W. FadA from Fusobacterium nucleatum utilizes both secreted and nonsecreted forms for functional oligomerization for attachment and invasion of host cells. J Biol Chem 2007, 282:25000-25009.
99. Temoin S., Wu K.L., Wu V., Shoham M., Han Y.W. Signal peptide of FadA adhesin from Fusobacterium nucleatum plays a novel structural role by modulating the filament's length and width. FEBS Lett 2012, 586:1-6.
100. Han Y.W., Ikegami A., Rajanna C., Kawsar H.I., Zhou Y., Li M., Sojar H.T., Genco R.J., Kuramitsu H.K., Deng C.X. Identification and characterization of a novel adhesin unique to oral fusobacteria. J Bacteriol 2005, 187:5330-5340.
101. Fardini Y., Wang X., Temoin S., Nithianantham S., Lee D., Shoham M., Han Y.W. Fusobacterium nucleatum adhesin FadA binds vascular endothelial cadherin and alters endothelial integrity. Mol Microbiol 2011, 82:1468-1480.
102. Edwards A.M., Grossman T.J., Rudney J.D. Fusobacterium nucleatum transports noninvasive Streptococcus cristatus into human epithelial cells. Infect Immun 2006, 74:654-662.
103. Gupta S., Ghosh S.K., Scott M.E., Bainbridge B., Jiang B., Lamont R.J., McCormick T.S., Weinberg A. Fusobacterium nucleatum-associated beta-defensin inducer (FAD-I): identification, isolation, and functional evaluation. J Biol Chem 2010, 285:36523-36531.
104. Park S.R., Kim D.J., Han S.H., Kang M.J., Lee J.Y., Jeong Y.J., Lee S.J., Kim T.H., Ahn S.G., Yoon J.H., et al. Diverse Toll-like receptors mediate cytokine production by Fusobacterium nucleatum and Aggregatibacter actinomycetemcomitans in macrophages. Infect Immun 2014, 82:1914-1920.
105. Lee P., Tan K.S. Fusobacterium nucleatum activates the immune response through retinoic acid-inducible gene I. J Dent Res 2014, 93:162-168.